Alkermes Signs US$950 M Deal with Rodin Therapeutics to Boost CNS Pipeline

By Michelle Liu

Pharma Deals Review: Vol 2019 Issue 11 (Table of Contents)

Published: 22 Nov-2019

DOI: 10.3833/pdr.v2019.i11.2471     ISSN: 1756-7874

Section: Mergers & Acquisitions



In a bid to bolster its CNS pipeline, Alkermes has agreed to acquire Rodin Therapeutics in a deal worth up to US$950 M...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details